Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
, Energy, Environment and Ecology
by ruth on October 12, 2006

"...These new resources will enable the company to expand its capabilities to address major global health and energy challenges, thereby helping to fulfill the promise of synthetic biology, ... In addition to its ongoing focus on creating a low-cost malaria drug, Amyris will add a new program aimed at renewably producing second-generation, high-performance biofuels with increased cost-effectiveness."
Amyris has a collaborative project with the University of California, Berkeley, and the Institute for One World Health (iOWH) to develop a cost-effective malaria treatment.
Read more from Amyris' press release.
Tags:
venture+funding
synthetic+biology
biofuels
malaria
biotech
raises+million
amyris+biotechnologies
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/39038
Mr Wong
Vote for Amyris Biotechnologies Raises $20 Million in Series A Funding:
|
Rating: 9.50 out of 2 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







